Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy by Nicolas Martin, Pierre Tricarico, David Chardin, Sara Contu, Florent Hugonnet, Josiane Otto, Olivier Humbert

Get full text

Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study by Marius Ilie, Jonathan Benzaquen, Jacques Darcourt, Nicolas Martin, David Chardin, Josiane Otto, Olivier Humbert, Marie Paquet, Renaud Schiappa, Caroline Bailleux, Michel Poudenx, Aurélie Sciazza

Get full text

Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer by Jonathan Benzaquen, Pierre-Yves Bondiau, Josiane Otto, Charles-Hugo Marquette, Jean-Philippe Berthet, Arash O. Naghavi, Renaud Schiappa, Jean-Michel Hannoun-Levi, Bernard Padovani, Jérôme Doyen

Get full text

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer by Wassila Khatir, Olivier Humbert, Jonathan Benzaquen, Christophe Bontoux, Jaap Neels, Léa Berland, Fabian Andrés Gallardo Rivera, Maryline Allegra, Myriam Salah, Virginie Tanga, Olivier Bordone, Julien Fayada, Virginie Lespinet‐Fabre, Doriane Bohly, Elodie Long‐Mira, Sandra Lassalle, Valérie Vouret, Patrick Brest, Baharia Mograbi, Charlotte Maniel, Josiane Otto, Jacques Boutros, Simon Heeke, Véronique Hofman, Charles‐Hugo Marquette, Paul Hofman, Marius Ilié

Get full text